Germany
· Delayed Price · Currency is EUR Bayer Aktiengesellschaft Company Description
Bayer Aktiengesellschaft operates as a life science company worldwide.
It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy.
The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, and self-care solutions in dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, and cold and cough.
The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture.
This segment provides breeding, propagation, and production/processing of seeds, including seed dressing.
It has a collaboration agreement with MD Anderson Cancer Center to develop oncology drugs; research and license agreement with Dewpoint Therapeutics, Inc. for the development of new treatments for cardiovascular and gynecological diseases; collaboration agreement with Exscientia Ltd, Foundation Medicine Inc., and Evotec AG; research collaboration with Arvinas Inc.; strategic research partnership with University of Oxford to develop novel gynecological therapies; Kyoto University to identify new drugs candidates for the treatment of pulmonary diseases; and collaboration and license agreement with Cytokinetics for the development and commercialization of aficamten.
It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers.
The company was founded in 1863 and is headquartered in Leverkusen, Germany.
| Country | Germany |
| Founded | 1952 |
| Industry | Drug Manufacturers - General |
| Sector | Healthcare |
| Employees | 96,931 |
| CEO | William Anderson |
Contact Details
Address: Kaiser-Wilhelm-Allee 1 Leverkusen, 51368 Germany | |
| Phone | 49 214 30 1 |
| Website | bayer.com |
Stock Details
| Ticker Symbol | BAYN |
| Exchange | Deutsche Börse Xetra |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| ISIN Number | DE000BAY0017 |
| SIC Code | 2800 |
Key Executives
| Name | Position |
|---|---|
| William N. Anderson | Chairman of the Management Board and Chief Executive Officer |
| Wolfgang U. Nickl | Chief Financial Officer and Member of Management Board |
| Stefan Oelrich | Head of the Pharmaceuticals Division and Member of the Board of Management |
| Rodrigo Santos | Member of Management Board and President of the Crop Science Division |
| Heike Prinz | Chief Talent Officer, Labor Director and Member of Management Board |
| Julio Triana | Member of Management Board and President of Consumer Health Division |
| Dr. Sebastian Guth Ph.D. | Chief Operating Officer |
| Amanda McClerren | Chief Information Officer, Head-Digital Transformation and IT-Crop Science Division |
| Dr. Jost Reinhard | Head of Investor Relations |
| Dr. Thomas Laubert | Head of Law, Patents and Compliance |